🔗 Permalink

Inventor profile of:

David HORNE

City:

Altadena, California

Country:

United States

Published Applications:

Last publication date:

2025-03-27

Top Assignees for applications by David HORNE

The entities that hold a legal rights for patent applications filed by inventor HORNE David:

CITY OF HOPE 34 Duarte, CA United States
The Regents of the University of California 5 Oakland, CA United States
National and Kapodistrian University of Athens 3 Athens, Greece

Recent patent applications by HORNE David

David HORNE from Altadena, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-27

US20250100962A1

Chemistry; metallurgy

CLOCK ACTIVATORS AND USES THEREOF

#2 | 2025-02-27

US20250066418A1

Chemistry; metallurgy

CYSTEINE PEPTIDE-ENABLED ANTIBODIES

#3 | 2024-12-26

US20240425584A1

Chemistry; metallurgy

MECHANICALLY INTERLOCKING COMPLEXES

#4 | 2024-10-17

US20240343682A1

Chemistry; metallurgy

PCNA INHIBITORS

#5 | 2023-05-04

US20230132808A1

Chemistry; metallurgy

WNT/CBP/CATENIN SIGNALING PATHWAY INHIBITORS AND USES THEREOF

#6 | 2023-04-27

US20230127630A1

Chemistry; metallurgy

IGF2BP2 INHIBITORS AND USES THEREOF

#7 | 2022-10-27

US20220340516A1

Chemistry; metallurgy

PCNA inhibitors

#8 | 2022-09-01

US20220274964A1

Chemistry; metallurgy

5-BROMO-INDIRUBINS

#9 | 2022-09-01

US20220273635A1

Human necessities

Solution formulations of CX-011

#10 | 2022-01-27

US20220023240A1

Human necessities

Compound for treating cancer and diabetes

#11 | 2022-01-06

US20220002231A1

Chemistry; metallurgy

PARG inhibitors and method of use thereof

#12 | 2021-11-18

US20210355103A1

Chemistry; metallurgy

PARG INHIBITORS AND METHOD OF USE THEREOF

#13 | 2021-05-20

US20210145840A1

Human necessities

T-cell lymphoma treatments

#14 | 2021-05-13

US20210139476A1

Chemistry; metallurgy

Pyridopyrazine compounds and uses thereof

#15 | 2021-04-22

US20210115066A1

Chemistry; metallurgy

Dithio ETP derivatives

#16 | 2021-03-18

US20210078938A1

Chemistry; metallurgy

PCNA inhibitors

#17 | 2021-02-25

US20210053919A1

Chemistry; metallurgy

5-Bromo-indirubins

#18 | 2021-01-28

US20210023238A1

Human necessities

TRIPTOLIDE ANTIBODY CONJUGATES

#19 | 2020-11-26

US20200368364A1

Human necessities

CYSTEINE PEPTIDE-ENABLED ANTIBODIES

#20 | 2020-11-05

US20200345693A1

Human necessities

Thioindirubins

#21 | 2020-09-10

US20200283421A1

Chemistry; metallurgy

5-bromo-indirubins

#22 | 2020-09-03

US20200277307A1

Chemistry; metallurgy

Synthesis of ETP derivatives

#23 | 2020-07-09

US20200216386A1

Chemistry; metallurgy

PCNA inhibitors

#24 | 2019-07-11

US20190211034A1

Chemistry; metallurgy

Dithio ETP derivatives

#25 | 2019-05-30

US20190161461A1

Chemistry; metallurgy

RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE

#26 | 2019-03-21

US20190083650A1

Human necessities

TKI permeability enhancers

#27 | 2018-11-29

US20180339960A1

Chemistry; metallurgy

PCNA inhibitors

#28 | 2018-06-21

US20180170915A1

Chemistry; metallurgy

5-BROMO-INDIRUBINS

#29 | 2018-06-21

US20180170870A1

Chemistry; metallurgy

5-bromo-indirubins

#30 | 2018-06-07

US20180155367A1

Chemistry; metallurgy

ETP derivatives

#31 | 2018-06-07

US20180155303A1

Chemistry; metallurgy

Ribonucleotide reductase inhibitors and methods of use

#32 | 2018-03-29

US20180086826A1

Chemistry; metallurgy

Mechanically interlocking complexes

#33 | 2017-05-18

US20170137392A1

Chemistry; metallurgy

Ribonucleotide reductase inhibitors and methods of use

#34 | 2017-02-09

US20170037058A1

Chemistry; metallurgy

ETP derivatives

#35 | 2016-12-08

US20160354327A1

Human necessities

Compound for treating cancer and diabetes

#36 | 2016-05-05

US20160122308A1

Chemistry; metallurgy

Ribonucleotide reductase inhibitors and methods of use

#37 | 2016-03-10

US20160068517A1

Chemistry; metallurgy

5-BROMO-INDIRUBINS

#38 | 2015-10-15

US20150291622A1

Chemistry; metallurgy

ETP derivatives

#39 | 2015-09-17

US20150259288A1

Chemistry; metallurgy

5-BROMO-INDIRUBINS

#40 | 2015-03-26

US20150087844A1

Chemistry; metallurgy

Ribonucleotide reductase inhibitors and methods of use

#41 | 2014-06-12

US20140162996A1

Chemistry; metallurgy

Modulators of development of adipocyte and cancer cells

#42 | 2014-06-05

US20140155423A1

Chemistry; metallurgy

Berbamine derivatives

#43 | 2012-10-04

US20120253048A1

Chemistry; metallurgy

Ribonucleotide reductase inhibitors and methods of use

#44 | 2011-10-06

US20110245304A1

Chemistry; metallurgy

Ribonucleotide reductase inhibitors and methods of use

#45 | 2010-11-25

US20100298369A1

Chemistry; metallurgy

Berbamine derivatives

#46 | 2009-10-15

US20090258915A1

Chemistry; metallurgy

Ribonucleotide reductase inhibitors and methods of use

InventorID:

787993 ⎘